Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Publication Details

New drugs creating new challenges in acute myeloid leukemia

Tiong, Ing S.; Wei, Andrew H.

(2019), GENE CHROMOSOME CANC, 58(12), 903-914

DOI: 10.1002/gcc.22750

Using par4 inhibition as an anti-thrombotic approach

Li, Simeng; Tarlac, Volga; Hamilton, Justin R.

(2019), INT J MOL SCI, 20(22), 5629

DOI: 10.3390/ijms20225629

Clinicopathological aspects of therapy-related acute myeloid leukemia and myelodysplastic syndrome

Chua, Chong Chyn; Fleming, Shaun; Wei, Andrew H.

(2019), BEST PRACT RES CL HA, 32(1), 3-12.

DOI: 10.1016/j.beha.2019.02.007

Venetoclax combined with low-dose cytarabine for previously untreated patients with acute myeloid leukemia

Wei, Andrew H.; Strickland, Stephen A.; Hou, Jing Zhou; Fiedler, Walter; Lin, Tara L.; Walter, Roland B.; Enjeti, Anoop; Tiong, Ing Soo; Savona, Michael; Lee, Sangmin; Chyla, Brenda; Popovic, Relja; Salem, Ahmed Hamed; Agarwal, Suresh; Xu, Tu; Fakouhi, Kaffa M.; Humerickhouse, Rod; Hong, Wan Jen; Hayslip, John; Roboz, Gail J.

(2019), J CLIN ONCOL, 37(15), 1277-1284.

DOI: 10.1200/JCO.18.01600

Polyclonal heterogeneity: The New Norm for Secondary Clinical Resistance to Targeted Monotherapy in Relapsed Leukemia?

Wei, Andrew H.; Roberts, Andrew W.

(2019), CANCER DISCOV, 9(8), 998-1000.

DOI: 10.1158/2159-8290.CD-19-0575

Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts.

Wei, Andrew; Angenendt, Linus; Röllig, Christoph; Montesinos, Pau; Martínez-Cuadrón, David; Barragán, Eva; García, Raimundo; Botella, Carmen; Martínez, Pilar; Ravandi, Farhad; Kadia, Tapan; Kantarjian, Hagop M.; Cortes, Jorge; Juliusson, Gunnar; Lazarevic, Vladimir; Höglund, Martin; Lehmann, Sören; Recher, Christian; Pigneux, Arnaud; Bertoli, Sarah; Dumas, Pierre-Yves; Dombret, Hervé; Preudhomme, Claude; Micol, Jean-Baptiste; Terré, Christine; Ráčil, Zdeněk; Novak, Jan; Zak, Pavel; Tiong, Ing Soo; Wall, Meaghan; Estey, Elihu; Shaw, Carole; Exeler, Rita; Wagenführ, Lisa

(2019), J CLIN ONCOL, 37(29), 2632-2642.

DOI: 10.1200/JCO.19.00416

BCL-2 family protein BOK is a positive regulator of uridine metabolism in mammals

Srivastava, Rahul; Cao, Zhipeng; Nedeva, Christina; Naim, Samara; Bachmann, Daniel; Rabachini, Tatiana; Gangoda, Lahiru; Shahi, Sanjay; Glab, Jason; Menassa, Joseph; Osellame, Laura; Nelson, Tao; Fernandez-Marrero, Yuniel; Brown, Fiona; Wei, Andrew; Ke, Francine; O'Reilly, Lorraine; Doerflinger, Marcel; Allison, Cody; Kueh, Andrew; Ramsay, Rob; Smith, Brian J.; Mathivanan, Suresh; Kaufmann, Thomas; Puthalakath, Hamsa

(2019), P NATL ACAD SCI USA, 116(31), 15469-15474.

DOI: 10.1073/pnas.1904523116

Incorporating precision BH3 warheads into the offensive against acute myeloid leukemia

Savona, Michael R.; Wei, Andrew H.

(2019), J CLIN ONCOL, 37(21), 1785-1789.

DOI: 10.1200/JCO.19.00400

ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms

Goossens, Steven; Wang, Jueqiong; Tremblay, Cedric S.; De Medts, Jelle; T'sas, Sara; Nguyen, Thao; Saw, Jesslyn; Haigh, Katharina; Curtis, David J.; Van Vlierberghe, Pieter; Berx, Geert; Taghon, Tom; Haigh, Jody J.

(2019), HAEMATOLOGICA, 104(8), 1608-1616.

DOI: 10.3324/haematol.2018.207837

Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia

Dombret, Hervé; Topp, Max S.; Schuh, Andre C.; Wei, Andrew H.; Durrant, Simon; Bacon, Christopher Larry; Tran, Qui; Zimmerman, Zachary; Kantarjian, Hagop

(2019), LEUKEMIA LYMPHOMA, 60(9), 2214-2222

DOI: 10.1080/10428194.2019.1576872

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

DiNardo, Courtney D.; Pratz, Keith; Pullarkat, Vinod; Jonas, Brian A.; Arellano, Martha; Becker, Pamela S.; Frankfurt, Olga; Konopleva, Marina; Wei, Andrew H.; Kantarjian, Hagop M.; Xu, Tu; Hong, Wan Jen; Chyla, Brenda; Potluri, Jalaja; Pollyea, Daniel A.; Letai, Anthony

(2019), BLOOD, 133(1), 7-17.

DOI: 10.1182/blood-2018-08-868752

Adenosine and Forskolin Inhibit Platelet Aggregation by Collagen but not the Proximal Signalling Events

Clark, Joanne C.; Kavanagh, Deirdre M.; Watson, Stephanie; Pike, Jeremy A.; Andrews, Robert K.; Gardiner, Elizabeth E.; Poulter, Natalie S.; Hill, Stephen J.; Watson, Steve P.

(2019), THROMB HAEMOSTASIS, 119(7), 1124-1137.

DOI: 10.1055/s-0039-1688788

Utility of circulating cell-free RNA analysis for the characterization of global transcriptome profiles of multiple myeloma patients

Chen, Maoshan; Mithraprabhu, Sridurga; Ramachandran, Malarmathy; Choi, Kawa; Khong, Tiffany; Spencer, Andrew

(2019), CANCERS, 11(6), 887

DOI: 10.3390/cancers11060887

Utility of a Nurse-Led Pathway for Patients with Acute Venous Thromboembolism Discharged on Rivaroxaban

Lim, Ming Sheng; Indran, Tishya; Cummins, Anita; Bennett, Ashwini; Wood, Erica; Brown, Susan; McQuilten, Zoe; Tran, Huyen; Chan, Noel C.; Chunilal, Sanjeev

(2019), SEMIN THROMB HEMOST, 45(2), 187-195.

DOI: 10.1055/s-0038-1676320

Functional Brush Poly(2-ethyl-2-oxazine)s: Synthesis by CROP and RAFT, Thermoresponsiveness and Grafting Onto Iron Oxide Nanoparticles

Klein, Tobias; Parkin, Joshua; de Jongh, Patrick A.J.M.; Esser, Lars; Sepehrizadeh, Tara; Zheng, Gang; De Veer, Michael; Alt, Karen; Hagemeyer, Christoph E.; Haddleton, David M.; Davis, Thomas P.; Thelakkat, Mukundan; Kempe, Kristian

(2019), MACROMOL RAPID COMM, 40(10), 1800911

DOI: 10.1002/marc.201800911

Epigenetic treatment-mediated modulation of PD-L1 predicts potential therapy resistance over response markers in myeloid malignancies

Liu, Hongbin; Hu, Yunshan; Rimoldi, Rafael; Von Hagt, Chloe; Khong, Edmund W.C.; Lee, Nora; Flemming, Shaun; Spencer, Andrew; Dear, Anthony E.

(2019), ONCOL LETT, 17(2), 2543-2550.

DOI: 10.3892/ol.2018.9841

Exosomes Derived from Human Primary and Metastatic Colorectal Cancer Cells Contribute to Functional Heterogeneity of Activated Fibroblasts by Reprogramming Their Proteome

Rai, Alin; Greening, David W.; Chen, Maoshan; Xu, Rong; Ji, Hong; Simpson, Richard J.

(2019), PROTEOMICS, 19(8), 1800148

DOI: 10.1002/pmic.201800148

Combining BH3-Mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia

Moujalled, Donia M.; Pomilio, Giovanna; Ghiurau, Corina; Ivey, Adam; Salmon, Jessica; Rijal, Sewa; Macraild, Sarah; Zhang, Lan; Teh, Tse Chieh; Tiong, Ing Soo; Lan, Ping; Chanrion, Maia; Claperon, Audrey; Rocchetti, Francesca; Zichi, Adrien; Kraus-Berthier, Laurence; Wang, Youzhen; Halilovic, Ensar; Morris, Erick; Colland, Frédéric; Segal, David; Huang, David; Roberts, Andrew W.; Maragno, Ana Leticia; Lessene, Guillaume; Geneste, Olivier; Wei, Andrew H.

(2019), LEUKEMIA, 33(a), 905-917.

DOI: 10.1038/s41375-018-0261-3

Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients

Mithraprabhu, Sridurga; Morley, Rachel; Khong, Tiffany; Kalff, Anna; Bergin, Krystal; Hocking, Jay; Savvidou, Ioanna; Bowen, Kathryn M.; Ramachandran, Malarmathy; Choi, Kawa; Wong, Boris Ka Leong; Reynolds, John; Spencer, Andrew

(2019), LEUKEMIA, 33(8), 2022-2033.

DOI: 10.1038/s41375-019-0469-x

DNA-repair gene mutations are highly prevalent in circulating tumour dna from multiple myeloma patients

Mithraprabhu, Sridurga; Hocking, Jay; Ramachandran, Malarmathy; Choi, Kawa; Klarica, Daniela; Khong, Tiffany; Reynolds, John; Spencer, Andrew

(2019), CANCERS, 11(7), 917

DOI: 10.3390/cancers11070917